Private equity firm KKR & Co. Inc. KKR, +7.73% & Hologic Inc. HOLX, +1.04% have teamed up to create a platform aimed at accelerating innovations in medical technology. The initial focus will be on lung cancer – the leading cause for cancer deaths. Ajax Health will manage the platform, which will be called Maverix Medical. Duke Rohlen will oversee it. KKR will also contribute Serpex Medical, a portfolio company of Ajax. Serpex Medical is already developing technology that targets lung tissue to deliver therapy or for biopsy. KKR stock is up 61% year-to-date, while S&P 500 SPX, 0.09% is up 18.5%.